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Abstract
Background: While sleep disturbance is widespread in schizophrenia it is less clear whether sleep
disturbance is uniquely related to impaired coping and perceived quality of life.
Methods: We simultaneously assessed sleep quality, symptoms, and coping in 29 persons with
schizophrenia or schizoaffective disorder in a post acute phase of illness. Assessment instruments
included the Pittsburgh Sleep Quality Index; the Positive and Negative Symptom Scale; the
Heinrichs Quality of Life Scale; and the Ways of Coping Scale. Multiple regressions were performed
predicting quality of life and coping from sleep quality controlling for age and symptom severity. On
a subset of seven subjects non-dominant wrist actigraphy was used as an objective check of their
self-reported poor sleep.
Results: Analyses revealed that poor sleep quality predicted low quality of life (r = -0.493; p = .022)
and reduced preference for employing positive reappraisal when facing a stressor (r = -0.0594; p =
0.0012). Actigraphy confirmed poor sleep quality in a subset of subjects. They had shorter sleep
duration (p < .0005), shorter average sleep episodes (p < .005) and more episodes of long
awakening (p < 0.05) than community norms.
Conclusion: The results are consistent with the hypotheses that poor sleep may play a unique
role in sustaining poor quality of life and impaired coping in patients with schizophrenia. These
associations may hold for community controls as well.
Background
Many persons with schizophrenia report chronically dis-
turbed sleep [1,2]. Independent of the phase of illness,
sleep disturbance documented by polysomnography
include: difficulties falling asleep, awakening too early
and being unable to go back to sleep, a preference for
being awake during the evening, reduced deep or slow-
wave sleep (the most restorative stage of sleep), and short
REM latencies [3-6]. In addition to being a source of dis-
tress, various forms of sleep disturbance have also been
linked to heightened levels of thought disorder [7] and
symptoms of excitement [8] and may portend relapse [9].
While sleep disturbance appears widespread in schizo-
phrenia and is related to clinical features, less clear is
whether it is also related to impaired coping that charac-
terizes the disorder. Is poor sleep quality another factor
that uniquely contributes to the difficulties persons with
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schizophrenia experience coping with stressors, and sus-
taining relationships and work? There appear to be several
reasons to hypothesize that it may. Impaired sleep may
make it difficult for persons with schizophrenia to cope
with stressors [10]. Persons with schizophrenia and
impaired sleep might feel, for instance, especially
exhausted and highly inclined to avoid stressors and have
difficulty seeing the positive aspects of daily challenges.
Consistent with this, at least one study finds that damaged
sleep quality in schizophrenia relates to longer periods of
time spent in bed [2]. With low energy level and need for
more time in bed, it seems a matter of intuition that per-
sons might have great difficulty sustaining interpersonal
relationships and adapting to the demands of a work set-
ting. Additionally, beyond its effects on coping, we might
expect persons with impoverished sleep, irrespective of
their symptom level, to have less social and vocational sat-
isfaction than those with better sleep. Indeed, one study
indicates that sleep quality is associated with quality of
life for patients with schizophrenia [11].
To examine relationships between sleep quality, coping
and quality of life, we simultaneously assessed these
domains along with symptom level in a group of patients
with chronic schizophrenia and schizoffective disorder in
a post acute phase of illness. To assess sleep quality we
used the Pittsburgh Sleep Quality Index (PSI [12]), a
standardized self-assessment tool that gauges sleep qual-
ity during the past month. We chose the PSI because it has
been successfully used in several studies of persons with
schizophrenia [2,11,13,14]. To assess coping we used the
Ways of Coping Questionnaire (WCQ), a widely used
instrument that measures the relative degree of preference
for a number of coping strategies and which is sensitive to
the maladaptive coping preferences common to schizo-
phrenia [15]. To assess symptoms and quality of life, we
used two instruments that are the gold standard in schiz-
ophrenia research: the Positive and Negative Syndrome
Scale (PANSS [16]) and the Quality of Life Scale (QLS
[17]). We predicted that, controlling for levels of positive
and negative symptoms, poorer sleep quality would pre-
dict poorer quality of life overall, a greater preference for
avoidant coping, and a lesser preference for coping by
positive reappraisal.
Some doubt the abilities of persons with schizophrenia to
report their own sleep patterns accurately. However, a
study comparing polysomnography with subjective meas-
ures of sleep found that they were highly correlated in a
group of patients with chronic schizophrenia [18]. Simi-
larly, others found that persons with severe mental illness
can generally report the quality of their lives as well as
those with other non-psychiatric illnesses [19,20].
In addition, we wanted to know if actigraphy is an effec-
tive way of demonstrating sleep problems in the post-
acute phase of schizophrenia. To address this question, we
used actigraphy to monitor sleep patterns in a subset of
this patient population. Wrist actigraphy consists of mon-
itoring locomotor activity with a motion sensor slightly
bigger than a wrist-watch that is worn on the non-domi-
nant wrist. It is a common method used to assess sleep
[21]. Actigraphy is valid and reliable for evaluating sleep
patterns in insomnia, in diagnosing circadian rhythm dis-
orders, and in assessing sleep in subjects who are unlikely
to tolerate polysomnography [22]. There are small studies
that suggest the feasibility of using actigraphy in assess-
ments of sleep disturbance in patients with schizophrenia
[23,24].
Methods
Participants
All subjects met the Structured Clinical Interview for DSM
IV (SCID [25]) diagnosis DSM-IV-TR [26] criteria for
schizophrenia or schizoaffective disorder. All were in the
post acute phase of illness; with no hospitalizations or
medication changes for at least one month. Most were
patients with chronic schizophrenia who were in a VA day
treatment setting. All patient-subjects participated in an
informed consent procedure and signed informed con-
sent forms for this research. A tabulated summary of the
participants' characteristics is in Table 1.
Instruments
Actigraphy
Sensors (Model # 24.000, Ambulatory Monitoring Inc,
Ardsley, NY) slightly bigger than a wristwatch were worn
Table 1: Subject symptoms and demographics
Subject Characteristics Mean (S.D.)
Subjects Enrolled 29
Men 27
Women 2
Age 48 (7)
Education 12 (2)
Age at first hospitalization 25 (9)
Number of hospitalizations 12 (6)
SCID diagnosis
Schizophrenia 23
Schizoaffective disorder 6
PANSS components
Positive 19 (5)
Negative 19 (6)
Cognitive 19 (5)
Emotional 13 (4)
Excitement/Hostility 9 (3)
Medication (CPZ equiv.) 755 (752)BMC Psychiatry 2005, 5:13 http://www.biomedcentral.com/1471-244X/5/13
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by subjects on their non-dominant wrists for 21 days.
Actigraphic logs of the non-dominant arm have a high
correlation with gross locomotor activity [27]. Actigraphy
is validated and reliable for evaluating sleep patterns [22].
The data from each actigraph was processed by the soft-
ware included with the actigraphic monitors.
Pittsburgh Sleep Quality Index (PSI)
The PSI is an effective instrument used to measure the
quality and patterns of sleep. It differentiates "poor" from
"good" sleep by measuring seven subscales: Subjective
Sleep Quality, Sleep Latency, Sleep Duration, Habitual
Sleep Efficiency, Sleep Disturbances, Use of Sleeping Med-
ication, and Daytime Dysfunction over the last month.
The client self-rates each of these seven areas of sleep by
answering nine questions. Scoring of answers is based on
a zero to three scale, and a score of three reflects the nega-
tive extreme on the Likert Scale. A global sum of "5" or
greater indicates a "poor" sleeper. The PSI has internal
consistency and a reliability coefficient (Cronbach's
alpha) of 0.83 for its seven components. Numerous stud-
ies using the PSI have supported high validity and
reliability.
Positive and Negative Syndrome Scale (PANSS)
The PANSS is a 30 item rating scale completed by clini-
cally-trained research staff at the conclusion of chart
review and a semi-structured interview. For the purposes
of this study the five PANSS factor analytically derived
components are used: Positive, Negative, Cognitive,
Excitement and Emotional discomfort [28].
Quality of Life Scale (QLS [29])
The tool is a 21 item scale completed by clinically trained
staff after a semi-structured interview and chart review
that assesses quality of life. Items are scored on a 7-point
scale with higher ratings representing higher levels of sat-
isfaction. Items tap a range of essential aspects of psycho-
social interactions incorporating four subscales:
Interpsychic Foundations; Occupational Functions; Com-
monplace Objects; and Activities and Interpersonal Rela-
tionships. For the purposes of this study we used the sum
of all items as an index of overall quality of life. Interrater
reliability for this instrument has been reported to range
between 0.85 and 0.93 [15].
Ways of Coping Questionnaire (WCQ [30])
The WCQ is a self-report instrument that asks participants
to call to mind a recent stressor and then rate how often
they have used 66 different behaviours to cope with that
stressor. Scale scores are additively derived from individ-
ual items and divided by a total score to provide a relative
score. This relative score reflects participants' relative pref-
erences among a set of discrete coping strategies. Relative
scores are generally preferable because, among other
things, they control for response bias. For the purposes of
this study we calculated the relative scores for two sub-
scales: "Escape Avoidance," and "Positive Reappraisal."
Escape Avoidance describes wishful thinking and behav-
ioural efforts to actively escape or avoid the problem and
includes items such as: "I refused to believe it had hap-
pened" and "I wished the situation would go away or be
over with." Positive Reappraisal describes efforts to create
positive meaning by focusing on personal growth and
includes items such as: "I changed or grew as a person in
a good way" and "I found new faith." Internal consistency
assessed using Cronbach's alpha have been reported to
range from 0.61 to 0.79.
Procedures
Following informed consent participants were adminis-
tered the PSI. PANSS, QLS, and WCQ were completed
within the previous month for another study of the effects
of personality on function in schizophrenia. Diagnosis
was determined using the SCID. Ratings of sleep quality
were elicited by a research assistant blind to the results of
the PANSS, QLS and WCQ. We fitted a subset of patients
with actigraphs that they wore for 21 days.
Statistical analysis
The statistical analyses were Pearson correlations and
Mixed Models analyses in SAS® software. We also repeated
the correlations for patients with schizophrenia separate
from the patients with schizoaffective disorder.
Results
Mean scores ± SD on the tests were: Quality of Life total
51.73 ± 16.16; Pittsburgh Sleep Quality Index 11.6 ± 4.57;
Ways of Coping Questionnaire subscales: "Escape Avoid-
ance," 0.138 ± 0.062 and "Positive Reappraisal" 0.125 ±
0.079. There was no correlation between QLS and "Escape
Avoidance" scores, but a modest positive correlation
between QLS and "Positive Reappraisal" (r = 0.421, p =
0.021).
To examine the associations between sleep and quality of
life we next performed partial correlations, using the PSI
total score to predict QLS total score and QLS subscores
with age and positive and negative component scores as
covariates. Similarly, we used PSI subscores to predict QLS
total score. Results revealed that poor sleep was related to
poor quality of life (total PSI vs total QLS, r = -0.493; p =
.022). The PSI accounted for 24% of the variance in QLS.
Total PSI did not correlate with any of the QLS subscores.
The PSI subscores: "Subjective Sleep Quality", "Sleep
Duration", and "Sleep Disturbances" correlated with total
QLS at p < 0.05 but none were significant after making the
Bonferroni correction for multiple comparisons.BMC Psychiatry 2005, 5:13 http://www.biomedcentral.com/1471-244X/5/13
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To examine the associations between sleep and coping
style we next performed partial correlations, using the PSI
total score to predict WCQ Escape Avoidance, and WCQ
Positive Reappraisal score with age and positive and neg-
ative component scores as covariates. Results revealed that
poor sleep was related to a reduced preference for Positive
Reappraisal (r = -0.594; p = 0.0012). Sleep quality was
found to be unrelated to Escape Avoidance. The PSI
accounted for over 37 % of the variance in coping.
Patients with schizoaffective disorder had worse sleep as
measured by the PSI than did patients with schizophrenia
(13.7 ± 4.4 versus 9.7 ± 4.7; t-test, p = 0.03). The two
groups did not differ in total scores of the QLS or WCQ.
The correlations between total PSI and total QLS, and
between total PSI and Positive Reappraisal for patients
with schizophrenia were significant (r = -0.516; p = 0.039
and r = -0.645; p = 0.006 respectively). The same correla-
tions were not significant for patients with schizoaffective
disorder.
Seven participants with schizophrenia accepted the activ-
ity monitors and were willing to wear them continually
for up to 3 weeks. Seven patients completed actigraphic
monitoring, and the actigraphic results are in Table 2.
Actigraphy verified that participants with schizophrenia
had less overall sleep and more interrupted sleep than
published community norms.
Discussion
The results are consistent with the hypothesis that poor
quality sleep that typically characterizes schizophrenia
may have a powerful impact on both patients' perception
of their quality of life and their ability to cope with stress.
Independent of age and symptoms, poorer sleep quality
predicted poorer quality of life and greater difficulties
appraising stressors in a positive light. This may suggest
that among the deficits accompanying schizophrenia,
poor sleep is often underappreciated. Impaired sleep may
erode the ability of schizophrenic patients to cope with
the routine stress associated with work and interpersonal
relationships. Furthermore, chronic sleep deprivation
may contribute to anergy that impairs attendance and
work performance. Since the found associations are inde-
pendent of symptom level they may be trait variables.
These findings are consistent with polysomnographic
studies of sleep in schizophrenia which show that many
sleep deficits that are not dependent on the acuity of ill-
ness [3-7]. The findings are also consistent with a prior
study of sleep quality and quality of life in patient with
schizophrenia [11]. We had an insufficient number of
participants to confirm a correlation between PSI sub-
scores and total Quality of Life.
The negative relationship between complaints of poor
sleep quality and Preference for coping by Positive Reap-
praisal remained significant when the confounding effects
of symptom acuity and age were partialled from the corre-
lation matrix. One interpretation is that chronically dis-
turbed sleep may erode both the ability to find positive
meaning and the desire to achieve personal growth. Given
the correlative nature of the data analysis, however, it is
not possible to infer causality. It may be that poor coping
or poor quality of life lead to greater difficulties sleeping
or that another unmeasured variable may account for the
relationships. We plan future longitudinal studies that
may uncover if sleep changes typically precede or follow
changes in either coping or quality of life.
There are other limitations to this study; most participants
were male and in their 40s. Further experiments will be
needed which include females and males in earlier phases
of illness. The association of disturbed sleep and both
quality of life and coping may hold for community con-
trols as well.
Conclusion
These findings may have important clinical implications.
If poor sleep quality is indeed a critical factor in quality of
life and coping impairments in schizophrenia, clinicians
will need to focus on and aggressively treat sleep prob-
lems. Specific treatments could include training in sleep
hygiene with a focus on regular waking and sleep times,
avoiding naps, morning bright light, evening melatonin,
or other hypnotic agents. Improved sleep may lead to
improved ability to cope with stress, and increased energy.
These would improve the quality of life and coping in
patients with schizophrenia.
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Table 2: Sleep measures for subject subset and controls*
Sleep Measure Means Patients Controls Units
Participants 7 >200
Sleep Duration 1359 c 1440 min/d
Sleep Proportion 25 33 % of d
# of Long Awake Episodes 10.2 a 6.7 ea d
Mean Sleep Episode 28 b 60 min
Longest Sleep Episode 105 c 231 min
*Controls data provided by Ambulatory Monitoring
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